Literature DB >> 10476042

CADASIL: hereditary disease of arteries causing brain infarcts and dementia.

H Kalimo1, M Viitanen, K Amberla, V Juvonen, R Marttila, M Pöyhönen, J O Rinne, M Savontaus, S Tuisku, B Winblad.   

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) begins with migraine with aura in approximately one-third of the patients. More severe symptoms of recurrent strokes usually appear at 30-50 years of age. However, well before the first stroke, CADASIL may be diagnosed on the basis of characteristic hyperintensities in T2-weighted magnetic resonance images. Multiple lacunar infarcts located mainly in the basal ganglia and frontal white matter lead to a cognitive decline and finally to dementia. These infarcts result from a thickening and fibrosis of the walls of the small and medium-sized penetrating arteries with consequent obliteration and/or thrombosis. Although the symptoms are almost exclusively neurological, the arteriopathy is generalized. Thus, basophilic, periodic acid-Schiff-positive and, in electron microscopy, osmiophilic material accumulates between degenerating smooth muscle cells. This occurs even in dermal arteries, which renders skin a useful target for diagnostic biopsy. Presently, no specific therapy is available. CADASIL is caused by missense point mutations in the Notch3 gene, which encodes a transmembrane receptor protein. Each gene defect leads to either a gain or loss of a cysteine residue in the extracellular, N-terminal domain of the molecule, which most probably results in conformational alteration. The function of Notch3 in adults and the pathogenesis of CADASIL are still unknown.

Entities:  

Mesh:

Year:  1999        PMID: 10476042     DOI: 10.1046/j.1365-2990.1999.00198.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  9 in total

1.  Novel pathological features and potential therapeutic approaches for CADASIL: insights obtained from a mouse model of CADASIL.

Authors:  Xiao-Yun Liu; Maria E Gonzalez-Toledo; Austin Fagan; Wei-Ming Duan; Yanying Liu; Siyuan Zhang; Bin Li; Chun-Shu Piao; Lila Nelson; Li-Ru Zhao
Journal:  Ther Targets Neurol Dis       Date:  2014-12-02

2.  Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  James F Meschia; Cheryl Bushnell; Bernadette Boden-Albala; Lynne T Braun; Dawn M Bravata; Seemant Chaturvedi; Mark A Creager; Robert H Eckel; Mitchell S V Elkind; Myriam Fornage; Larry B Goldstein; Steven M Greenberg; Susanna E Horvath; Costantino Iadecola; Edward C Jauch; Wesley S Moore; John A Wilson
Journal:  Stroke       Date:  2014-10-28       Impact factor: 7.914

3.  NOTCH3 mutations in a cohort of Portuguese patients within CADASIL spectrum phenotype.

Authors:  Maria Rosário Almeida; Inês Elias; Carolina Fernandes; Rita Machado; Orlando Galego; Gustavo Santo
Journal:  Neurogenetics       Date:  2021-12-01       Impact factor: 2.660

4.  Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease.

Authors:  Anne Joutel; Marie Monet-Leprêtre; Claudia Gosele; Céline Baron-Menguy; Annette Hammes; Sabine Schmidt; Barbara Lemaire-Carrette; Valérie Domenga; Andreas Schedl; Pierre Lacombe; Norbert Hubner
Journal:  J Clin Invest       Date:  2010-01-11       Impact factor: 14.808

5.  Redistribution of Mature Smooth Muscle Markers in Brain Arteries in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy.

Authors:  John R Gatti; Xiaojie Zhang; Ejona Korcari; Soo Jung Lee; Nya Greenstone; Jon G Dean; Snehaa Maripudi; Michael M Wang
Journal:  Transl Stroke Res       Date:  2018-06-22       Impact factor: 6.829

6.  Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Authors:  Marie Magdeleine Ruchoux; Valérie Domenga; Peggy Brulin; Jacqueline Maciazek; Sylvie Limol; Elisabeth Tournier-Lasserve; Anne Joutel
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

7.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy in an Israeli family.

Authors:  Radi Shahien; Silvia Bianchi; Abdalla Bowirrat
Journal:  Neuropsychiatr Dis Treat       Date:  2011-06-20       Impact factor: 2.570

8.  SQSTM1 gene as a potential genetic modifier of CADASIL phenotype.

Authors:  Maria Rosário Almeida; Ana Rita Silva; Inês Elias; Carolina Fernandes; Rita Machado; Orlando Galego; Gustavo Cordeiro Santo
Journal:  J Neurol       Date:  2020-11-20       Impact factor: 4.849

9.  Progression and Classification of Granular Osmiophilic Material (GOM) Deposits in Functionally Characterized Human NOTCH3 Transgenic Mice.

Authors:  Gido Gravesteijn; Leon P Munting; Maurice Overzier; Aat A Mulder; Ingrid Hegeman; Marc Derieppe; Abraham J Koster; Sjoerd G van Duinen; Onno C Meijer; Annemieke Aartsma-Rus; Louise van der Weerd; Carolina R Jost; Arn M J M van den Maagdenberg; Julie W Rutten; Saskia A J Lesnik Oberstein
Journal:  Transl Stroke Res       Date:  2019-10-30       Impact factor: 6.829

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.